- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06933667
Kimel Family Centre for Brain Health and Wellness
April 10, 2025 updated by: Baycrest
Participants (n=450; aged 50+; without a diagnosis of dementia; sufficiently fluent in English to complete the assessments and engage in programming) receive a comprehensive dementia risk assessment, including nonmodifiable and modifiable risk factors, from which they receive a Personalized Dementia Risk Report and Program Strategy, indicating their health conditions increasing and their risk level in five modifiable risk domains: physical activity, brain- healthy eating, cognitive engagement, social connections, and mental wellbeing.
Equipped with this information, participants enroll in programs within the Centre to address their risk factors.
Changes to their dementia risk, cognition, and Personalized Program Strategy are communicated through re-assessments of risk factors every six months (risk and cognition) and every year (comprehensive assessment).
Study Overview
Status
Recruiting
Conditions
Detailed Description
Participants (n=450; aged 50+; without a diagnosis of dementia; sufficiently fluent in English to complete the assessments and engage in programming) complete a baseline assessment consisting of three parts.
A biosample session in which blood is drawn to measure HbA1c, cholesterols, thyroid levels, c-reactive protein, interleukin-6, homocysteine, and BDNF, and a saliva sample is provided to provide a polygenic risk score for AD.
A questionnaire session is completed on a tablet or from home asks about demographics, health conditions, and five targeted modifiable factors: physical activity, brain-healthy eating, cognitive engagement, social connections, and mental wellbeing.
A clinical session measures vitals, sensory function, frailty markers (grip strength, DXA, ultrasound of right quadriceps muscle), dual-task gait, and cognition (MoCA and Cogniciti's Brain Health Assessment).
From that assessment, participants receive a Personalized Dementia Risk Report and Program Strategy, outlining conditions that are known to increase dementia risk, with resources provided on how to get them addressed, as well as their risk level in the five targeted domains.
Participants then take a SMART goal setting workshop to identify SMART goals addressing their dementia risk factors, and then sign up for programming in the centre to reduce their risk.
After six months, their risk in the five targeted domains, cognition (Brain Health Assessment), and satisfaction are re-assessed, and every year, most of the baseline assessment is repeated.
We expect that this personalized approach will result in reductions in risk in the five targeted domains within the first six months, improvements in health factors within the first year, and improvements in cognition within two years.
Study Type
Interventional
Enrollment (Estimated)
450
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Nicole D. Anderson, PhD, CPsych
- Phone Number: 3366 416-785-2500
- Email: nanderson@research.baycrest.org
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M6A 2E1
- Recruiting
- Baycrest
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Aged 50 years or older
- Sufficiently fluent in English to complete the assessments and participate in programming.
Exclusion Criteria:
- Diagnosis of dementia.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Physical Activity
Participants are encouraged to work up to the Canadian Guidelines of 150 minutes a week of moderate to vigorous activity and to focus on balance and stretching.
|
Participants can chose (with input from a kinesiologist as required) from courses of varying intensity in our gym, warm water pool, or classrooms.
|
|
Active Comparator: Brain-healthy Eating
Participants are recommended to take five required courses about the CCNA Brain Health Food Guide, then take additional courses of their choice.
|
Participants take five foundational courses: Brain-healthy eating, Healthy protein choices, Colour your diet: Maximize the benefits of fruits and vegetables; Interpreting nutrition facts labels; and Salt and sugar: How much is too much?
They are also encouraged to take additional nutrition programs.
|
|
Active Comparator: Cognitive Engagement
Participants are encouraged to participate in at least one hour of cognitively engaging programs.
|
Participants can sign up for any lecture, discussion group, book club, creative arts program, etc. linked to the Cognitive Engagement risk factor.
|
|
Active Comparator: Social Connections
All programs, regardless of type, encourage social connections, through ice-breakers, peer mentoring, and time to chat before and after classes.
|
Social Connections are baked into all other programming.
Our instructors are trained in how to foster connections among participants, through peer coaching, ice-breakers, etc., and are asked to leave some time at the beginning and end of programs for participants to chat.
We also hold special social events such as game nights.
|
|
Active Comparator: Mental Wellbeing
Participants are encouraged to participate in at least one hour of programming focused on mental wellbeing (e.g., meditation, relaxation).
|
Participants are encouraged to enroll in one a week of relevant programming (e.g., meditation, relaxation).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Physical Activity
Time Frame: Every six months over two years.
|
Hours of moderate-to-vigorous physical activity a week, as determined by the CHAMPS (0 - 168, with higher scores indicating greater activity).
|
Every six months over two years.
|
|
Cognition
Time Frame: We expect to see this at the two year mark.
|
We expect cognition to be maintained or improved, as assessed by Cogniciti's Brain Health Assessment, to the extent that participants adhere to their Personalized Program Strategy.
|
We expect to see this at the two year mark.
|
|
Brain-Healthy Eating
Time Frame: Every six months over two years.
|
Brain-healthy eating as assessed by the Brain Health Food Guide derived Eating Pattern Self-Assessment (range 0 - 15, with higher scores indicating greater adherence to the Brain Health Food Guide).
|
Every six months over two years.
|
|
Cognitive Engagement
Time Frame: Every six months over two years.
|
Amount of engagement in higher-order cognitively engaging activities, as assessed by the Higher Cognition subscale of the Florida Cognitive Activities Scale (range 0-40, with higher scores indicated greater engagement).
|
Every six months over two years.
|
|
Social Connections
Time Frame: Every six months over two years.
|
Degree of loneliness as assessed by the UCLA Loneliness Scale (Version 3; range = 0-80, where higher scores indicate greater loneliness).
|
Every six months over two years.
|
|
Mental Wellbeing
Time Frame: Every six months over two years.
|
A composite of depression, anxiety, and (dis)stress from the Depression, Anxiety, and Stress Scale-21 (DASS-21), as well as perceived stress from the Perceived Stress Scale (with each subscale converted to a percentage of maximum and summed; range: 0 - 400).
|
Every six months over two years.
|
|
Diastolic Blood Pressure
Time Frame: Every year over two years.
|
Diastolic Blood Pressure, which lower numbers indicated better blood pressure.
|
Every year over two years.
|
|
Systolic Blood Pressure
Time Frame: Every year over two years.
|
Systolic Blood Pressure, where lower numbers indicate better blood pressure
|
Every year over two years.
|
|
Percent body fat
Time Frame: Every year over two years.
|
Percent body fat as determined by dual-energy X-ray absorptiometry (DXA), where lower numbers indicate less body fat.
|
Every year over two years.
|
|
Low density lipoprotein
Time Frame: Every year over two years.
|
Low density lipoprotein, assessed via blood draw, where lower numbers indicate less cholesterol.
|
Every year over two years.
|
|
C-reactive protein
Time Frame: Every year over two years.
|
C-reactive protein, assessed via blood draw, where lower numbers indicate less inflammation.
|
Every year over two years.
|
|
Interleukin-6
Time Frame: Every year over two years.
|
Interleukin-6, assessed via blood draw, where lower numbers indicate less inflammation.
|
Every year over two years.
|
|
HbA1c
Time Frame: Every year over two years.
|
Hemoglobin A1C (HbA1c), measured through blood draw, where lower numbers indicate less blood sugar.
|
Every year over two years.
|
|
Cognition
Time Frame: Every six months over two years.
|
Cognition, assessed as an age- and sex-adjusted percentile on the Brain Health Assessment (an online cognitive assessment of episodic memory, working memory, and executive functioning).
|
Every six months over two years.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nicole D. Anderson, PhD, CPsych, Baycrest
- Principal Investigator: Howard Chertkow, MD, Baycrest
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 26, 2024
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
August 31, 2027
Study Registration Dates
First Submitted
April 3, 2025
First Submitted That Met QC Criteria
April 10, 2025
First Posted (Actual)
April 18, 2025
Study Record Updates
Last Update Posted (Actual)
April 18, 2025
Last Update Submitted That Met QC Criteria
April 10, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- #23-26
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Participants are asked during consent if they consent to Open Science (as per Canadian TriCouncil Guidelines).
For those who do, we will deposit the data on the Open Science Framework within three years of study completion.
Data requests can also be made prior to this point by completing a Data Request Form (available from the PIs).
IPD Sharing Time Frame
The study protocol has been published (http://dx.doi.org/10.14283/jpad.2024.98); the only exception is that due to funding, we are not currently including the episodic future simulation aspect of that report.
That also describes our statistical analysis plan.
The analytic code will be posted on OSF with the primary paper(s).
IPD Sharing Access Criteria
When it is on OSF, anyone can access it.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Benuvia Therapeutics Inc.MandaraNot yet recruiting
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityCompletedDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeActive, not recruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityCompletedDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
NYU Langone HealthRecruiting
-
The University of Hong KongNot yet recruiting
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
Clinical Trials on Physical Activity
-
Zohra Institute of Health SciencesCompletedPhysical Activity and StressPakistan
-
Health Education Research Foundation (HERF)CompletedQuality of LifePakistan
-
University GhentCompleted
-
Centre Hospitalier Universitaire DijonWithdrawn
-
Fundacion para la Investigacion y Formacion en...CompletedImpaired CognitionSpain
-
Universidad Santo TomasEmory University; Universidad Pública de Navarra; Universidad de Granada; University... and other collaboratorsCompletedObesity | Lipid Metabolism Disorders | Mental Health Wellness 1 | Body Composition, Beneficial | Metabolic Syndrome X
-
Cardenal Herrera UniversityCompleted
-
Istituti Clinici Scientifici Maugeri SpACompleted
-
Assaf-Harofeh Medical CenterBen-Gurion University of the NegevUnknown
-
University of NottinghamBiotechnology and Biological Sciences Research CouncilRecruitingMetabolic Syndrome | Sedentary Behavior | Age-related Cognitive Decline | Age-Related SarcopeniaUnited Kingdom